Ankle–brachial pressure index

From WikiMD's WELLNESSPEDIA

An index used to measure peripheral artery disease

The Ankle–Brachial Pressure Index (ABPI) is a simple, non-invasive test used to assess the presence of peripheral artery disease (PAD). It compares the blood pressure in the ankle with the blood pressure in the arm.

Diagram illustrating the measurement of the Ankle–Brachial Pressure Index

Measurement[edit]

The ABPI is calculated by dividing the systolic blood pressure at the ankle by the systolic blood pressure in the arm. The procedure involves the following steps:

  1. The patient is asked to lie down in a supine position.
  2. A blood pressure cuff is placed around the arm to measure the brachial systolic pressure using a Doppler ultrasound device.
  3. The same procedure is repeated at the ankle, measuring the systolic pressure at the posterior tibial artery and the dorsalis pedis artery.
  4. The highest of the two ankle pressures is used to calculate the ABPI.

Interpretation[edit]

The ABPI is interpreted as follows:

  • 1.0 to 1.4: Normal
  • 0.9 to 1.0: Acceptable
  • 0.8 to 0.9: Some arterial disease
  • 0.5 to 0.8: Moderate arterial disease
  • < 0.5: Severe arterial disease

A low ABPI indicates reduced blood flow to the limbs, suggesting the presence of peripheral artery disease. An ABPI greater than 1.4 may indicate stiff arteries, which can occur in conditions such as diabetes mellitus or chronic kidney disease.

Clinical Significance[edit]

The ABPI is a valuable tool in the diagnosis and management of peripheral artery disease. It helps in assessing the severity of the disease and in monitoring the effectiveness of treatment. A low ABPI is associated with an increased risk of cardiovascular disease and stroke.

Limitations[edit]

While the ABPI is a useful screening tool, it has limitations. It may not be accurate in patients with calcified arteries, such as those with diabetes or advanced age, where the arteries are non-compressible. In such cases, additional tests like toe-brachial index or imaging studies may be required.

Related pages[edit]

Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.